Phase 1A Safety Trial of Inhaled PK10571 (GB002)

NCT03473236 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Safety Issues

Interventions

DRUG: GB002
DEVICE: Generic Dry Powder Inhaler
DRUG: Placebo

Sponsor

GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.

Collaborators

[object Object]
[object Object]